Belgian Medicines Agency backs up EU awareness campaign on side effects of medicines
08 November 2016
The Belgian Federal Agency for medicines and health products (FAMHP) has announced its participation in the EU’s awareness campaign on the possible side effects of medicines. The campaign will not be implemented through a platform on the EU-level, but at the national level (Belgian campaign available here). The FAMHP will participate in the campaign by raising awareness among patients and health professionals, illustrating the importance of notifications and clarifying how they can be made.
A prior version of this post was originally published by the same authors in Practical Law – Life Sciences, November 2016 Issue (Thomson Reuters).